Intraocular Inflammation following Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in Japanese Patients: Meta analysis using individual patient data
Not Applicable
- Conditions
- nAMD
- Registration Number
- JPRN-UMIN000049461
- Lead Sponsor
- Jichi Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1351
Inclusion Criteria
Not provided
Exclusion Criteria
Patients were excluded if he/she had a prophylactic treatment(s) for IOI, including topical administration of steroids
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method